This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Special Newsflash: Exenatide Once Weekly -- FDA Update

Posted: Tuesday, March 16, 2010

Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).

In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests raised in the letter primarily relate to the finalization of the product labeling with accompanying Risk Evaluation and Mitigation Strategy (REMS) and clarification of existing manufacturing processes.

Stinky Diabetes Drug May Result in Poor Adherence

Posted: Sunday, March 14, 2010

An immediate-release form of the antidiabetic agent metformin has a dead fish odor that may cause patients to stop taking the drug, clinicians warned.

Increasing Vitamin D Can Reduce Type 2 Diabetes by 55 Percent

Posted: Sunday, March 07, 2010

People who get plenty of vitamin D can cut their chance of developing Type 2 diabetes by 55 percent, according to the review of over 100,000 people in 28 studies.

TZD Patients Are 50% More Likely to Develop Bone Fractures

Posted: Sunday, March 07, 2010

A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD's to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.

Different Oral Antidiabetics Associated with Different Adverse Outcomes?

Posted: Sunday, March 07, 2010

Risk of cardiovascular disease and all-cause mortality among patients with Type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Dialysis Patients: Fatigue May Predict Heart Attack

Posted: Sunday, March 07, 2010

For dialysis patients, high scores on a new fatigue rating scale predict an increased risk of heart attack or other cardiovascular events, according to a new study.

FDA Reviewers Urge Pulling Rosiglitazone

Posted: Sunday, February 28, 2010

Two FDA reviewers have recommended that the diabetes drug rosiglitazone (Avandia) be pulled from the market because of its link to major cardiac events.

Pramlintide + Metreleptin Combo Moving Forward for Treatment of Obesity

Posted: Sunday, February 28, 2010

Amylin and Takeda announce decision to advance development of pramlintide/metreleptin combination treatment for obesity.

Chocolate Linked to Lower Stroke and Stroke Mortality Risk

Posted: Sunday, February 28, 2010

A new systematic review suggests higher chocolate consumption may be associated with a lower risk for incident stroke and stroke-related mortality.

LifeScan Recalls Specific Lots of Consumer and Professional OneTouch® SureStep® Test Strips Due To Inaccurate Readings at High Levels

Posted: Friday, February 26, 2010

LifeScan, Inc. is conducting a voluntary recall in the United States of eight lots of OneTouch® SureStep® Test Strips, used by people with diabetes to measure their blood glucose levels at home. The test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL.